AORT
Price
$23.48
Change
-$0.01 (-0.04%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
873.56M
50 days until earnings call
XRAY
Price
$15.92
Change
-$0.13 (-0.81%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
6.69B
50 days until earnings call
Ad is loading...

AORT vs XRAY

Header iconAORT vs XRAY Comparison
Open Charts AORT vs XRAYBanner chart's image
Artivion
Price$23.48
Change-$0.01 (-0.04%)
Volume$1.64K
Capitalization873.56M
DENTSPLY SIRONA
Price$15.92
Change-$0.13 (-0.81%)
Volume$60.75K
Capitalization6.69B
AORT vs XRAY Comparison Chart
Loading...
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AORT vs. XRAY commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AORT is a Hold and XRAY is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (AORT: $23.50 vs. XRAY: $16.05)
Brand notoriety: AORT and XRAY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AORT: 186% vs. XRAY: 106%
Market capitalization -- AORT: $873.56M vs. XRAY: $6.69B
AORT [@Medical Specialties] is valued at $873.56M. XRAY’s [@Medical Specialties] market capitalization is $6.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AORT’s FA Score shows that 0 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • AORT’s FA Score: 0 green, 5 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, XRAY is a better buy in the long-term than AORT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AORT’s TA Score shows that 3 TA indicator(s) are bullish while XRAY’s TA Score has 3 bullish TA indicator(s).

  • AORT’s TA Score: 3 bullish, 4 bearish.
  • XRAY’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, AORT is a better buy in the short-term than XRAY.

Price Growth

AORT (@Medical Specialties) experienced а -6.49% price change this week, while XRAY (@Medical Specialties) price change was +0.38% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.23%. For the same industry, the average monthly price growth was -7.25%, and the average quarterly price growth was -3.81%.

Reported Earning Dates

AORT is expected to report earnings on May 01, 2025.

XRAY is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Medical Specialties (-1.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XRAY($6.69B) has a higher market cap than AORT($874M). AORT has higher P/E ratio than XRAY: AORT (434.78) vs XRAY (19.23). XRAY YTD gains are higher at: -15.437 vs. AORT (-17.803). XRAY has higher annual earnings (EBITDA): 249M vs. AORT (26.8M). XRAY has more cash in the bank: 334M vs. AORT (58.9M). AORT has less debt than XRAY: AORT (358M) vs XRAY (2.3B). XRAY has higher revenues than AORT: XRAY (3.97B) vs AORT (354M).
AORTXRAYAORT / XRAY
Capitalization874M6.69B13%
EBITDA26.8M249M11%
Gain YTD-17.803-15.437115%
P/E Ratio434.7819.232,261%
Revenue354M3.97B9%
Total Cash58.9M334M18%
Total Debt358M2.3B16%
FUNDAMENTALS RATINGS
AORT vs XRAY: Fundamental Ratings
AORT
XRAY
OUTLOOK RATING
1..100
5057
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9193
PRICE GROWTH RATING
1..100
9641
P/E GROWTH RATING
1..100
7586
SEASONALITY SCORE
1..100
2350

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (3) in the Medical Specialties industry is significantly better than the same rating for AORT (94). This means that XRAY’s stock grew significantly faster than AORT’s over the last 12 months.

XRAY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as AORT (100). This means that XRAY’s stock grew similarly to AORT’s over the last 12 months.

AORT's SMR Rating (91) in the Medical Specialties industry is in the same range as XRAY (93). This means that AORT’s stock grew similarly to XRAY’s over the last 12 months.

XRAY's Price Growth Rating (41) in the Medical Specialties industry is somewhat better than the same rating for AORT (96). This means that XRAY’s stock grew somewhat faster than AORT’s over the last 12 months.

AORT's P/E Growth Rating (75) in the Medical Specialties industry is in the same range as XRAY (86). This means that AORT’s stock grew similarly to XRAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AORTXRAY
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
65%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
72%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
71%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 8 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
59%
Aroon
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X78532.000000-2069.039000
-2.57%
Bitcoin cryptocurrency
SPY560.58-15.34
-2.66%
SPDR® S&P 500® ETF Trust
AAPL227.48-11.59
-4.85%
Apple
GME22.42-1.58
-6.58%
GameStop Corp
TSLA222.15-40.52
-15.43%
Tesla

AORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, AORT has been loosely correlated with MDT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AORT jumps, then MDT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AORT
1D Price
Change %
AORT100%
-2.81%
MDT - AORT
43%
Loosely correlated
-0.74%
OFIX - AORT
42%
Loosely correlated
-2.45%
TMO - AORT
41%
Loosely correlated
-0.92%
SIBN - AORT
41%
Loosely correlated
-3.95%
LIVN - AORT
40%
Loosely correlated
-5.49%
More

XRAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with HOLX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then HOLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
-1.65%
HOLX - XRAY
42%
Loosely correlated
+1.67%
LH - XRAY
40%
Loosely correlated
-3.52%
MMSI - XRAY
40%
Loosely correlated
-2.84%
QGEN - XRAY
39%
Loosely correlated
-2.16%
AORT - XRAY
39%
Loosely correlated
-2.81%
More